Internationally-based Jindal Steel submits informal offer for Thyssenkrupp's steel division
Thyssenkrupp, the German conglomerate, has received a non-binding bid for its steel division from Jindal Steel International. The Indian company announced the offer on September 16, 2025, with intentions to complete the DRI plant in Duisburg and invest over 1 billion in additional electric arc capacities, subject to approval by Thyssenkrupp management and consideration of employment, future viability, and green transformation at the German steel sites.
This potential acquisition is not the first move Thyssenkrupp has made in the steel industry. Last year, the company sold a 20% stake in Thyssenkrupp Steel Europe (TKSE) to Czech billionaire Daniel Kretinsky with the aim of eventually selling a further 30% stake to create a 50-50 joint venture.
The news about the offer by Jindal Steel has been met with positivity by Juergen Kerner, Thyssenkrupp's deputy supervisory board chairman and senior IG Metall member. Thyssenkrupp's shares have turned positive and are trading 2.1% higher following the news.
However, substantive discussions are now necessary to gain clarity on the most important open questions as soon as possible. Factors under consideration during the examination include economic sustainability, continuation of the green transformation, and employment at steel sites.
Meanwhile, Thyssenkrupp has shortlisted two private equity groups for a potential 1 million deal involving its elevator division. The bidders include Blackstone, Carlyle, and CPPIB, who have made a joint bid for Thyssenkrupp's lift unit.
The bid for TKSE will be closely examined by Thyssenkrupp. IG Metall, a powerful labor union, had previously criticized Kretinsky for not providing information about his strategic plans as a co-shareholder. The union's concerns may influence the outcome of the examination process.
As Thyssenkrupp navigates these potential deals, it is clear that the future of the company's steel division and elevator division are at a critical juncture. The decisions made in the coming weeks could have significant implications for the company's future.
Read also:
- Federal Funding Supports Increase in Family Medicine Residency Program, Focusing on Rural Health Developments
- Potential Role of DHA in Shielding the Brain from Saturated Fats?
- Alternative Gentle Retinoid: Exploring Bakuchiol Salicylate for Sensitive Skin
- Hanoi initiates a trial program for rabies control, along with efforts to facilitate the transition from the dog and cat meat trade industry.
